TYROSINE PHOSPHORYLATION OF CD19 IN PRE-B-CELLS AND MATURE B-CELLS

被引:79
|
作者
CHALUPNY, NJ
KANNER, SB
SCHIEVEN, GL
WEE, SF
GILLILAND, LK
ARUFFO, A
LEDBETTER, JA
机构
[1] The Bristol-Myers Squibb, Pharmaceutical Research Institute, Seattle, WA 98121
来源
EMBO JOURNAL | 1993年 / 12卷 / 07期
关键词
ACTIVATION; SH2; DOMAIN; SIGNALING;
D O I
10.1002/j.1460-2075.1993.tb05930.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cross-linking of B cell surface immunoglobulins (sIg) results in activation of mature B cells and stimulates a molecular signaling mechanism for antigen-specific B cell expansion and differentiation. This signaling pathway is dependent on tyrosine (Tyr) phosphorylation and results in the activation of sIg-associated src family kinases and p72SYK. Rapid Tyr phosphorylation occurs on multiple protein substrates. Here we show that activation of B cells by cross-linking sIg results in an increase in Tyr phosphorylation of the lineage-restricted B cell surface antigen CD19, and show that it is a major substrate of activated Tyr kinase following sIg stimulation. Lower levels of constitutive CD19 Tyr phosphorylation occurred in most sIg+ mature B cell lines examined and in normal dense tonsillar B cells. We also rind that when CD19 is Tyr-phosphorylated it becomes competent to interact with SH2 domains suggesting a mechanism whereby, following B cell activation, CD19 could be linked to intracellular signaling pathways. In sIg- pre-B cell lines, CD19 was expressed but was not constitutively phosphorylated on tyrosine. Upon CD19 cross-linking, Tyr phosphorylation of CD19 was induced in sIg- pre-B cell lines. CD19 cross-linking also directly induced Tyr phosphorylation of CD19 and other substrates in mature B cells. The ability of CD19 to signal in the absence of sIg expression may provide important stimulation in pre-B cell development.
引用
收藏
页码:2691 / 2696
页数:6
相关论文
共 50 条
  • [1] PRE-B-CELLS AND B-CELLS IN CHILDREN ON LEUKEMIA REMISSION MAINTENANCE TREATMENT
    PAOLUCCI, P
    HAYWARD, AR
    RAPSON, NT
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1979, 37 (02): : 259 - 266
  • [2] CELL-SURFACE ANTIGENS EXPRESSED BY SUBSETS OF PRE-B-CELLS AND B-CELLS
    MCKEARN, JP
    BAUM, C
    DAVIE, JM
    JOURNAL OF IMMUNOLOGY, 1984, 132 (01): : 332 - 339
  • [3] PHENOTYPE, FREQUENCY, AND EBV RESPONSIVENESS OF HUMAN MARROW B-CELLS AND PRE-B-CELLS
    HIBI, T
    CHAN, MA
    PETSCHE, D
    DOSCH, HM
    JOURNAL OF IMMUNOLOGY, 1986, 136 (09): : 3211 - 3218
  • [4] J-CHAIN BIOSYNTHESIS IN PRE-B-CELLS AND OTHER POSSIBLE PRECURSOR B-CELLS
    MCCUNE, JM
    FU, SM
    KUNKEL, HG
    JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (01): : 138 - 145
  • [5] IMMUNOFLUORESCENCE STUDIES ON THE EXPRESSION OF VH A ALLOTYPES BY PRE-B-CELLS AND B-CELLS OF HOMOZYGOUS AND HETEROZYGOUS RABBITS
    GATHINGS, WE
    MAGE, RG
    COOPER, MD
    LAWTON, AR
    YOUNGCOOPER, GO
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (03) : 200 - 206
  • [6] CD19 IS A SUBSTRATE OF THE ANTIGEN RECEPTOR-ASSOCIATED PROTEIN-TYROSINE KINASE IN HUMAN B-CELLS
    ROIFMAN, CM
    KE, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (01) : 222 - 225
  • [7] CD34+ PRE-B-CELLS IN MONOCLONAL GAMMOPATHIES
    FRUEHAUF, S
    HAAS, R
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 748 - 748
  • [8] TYROSINE PHOSPHORYLATION OF THE VAV PROTOONCOGENE PRODUCT IN ACTIVATED B-CELLS
    BUSTELO, XR
    BARBACID, M
    SCIENCE, 1992, 256 (5060) : 1196 - 1199
  • [9] DISTINCTIVE GROWTH REQUIREMENTS AND GENE-EXPRESSION PATTERNS DISTINGUISH PROGENITOR B-CELLS FROM PRE-B-CELLS
    FAUST, EA
    SAFFRAN, DC
    TOKSOZ, D
    WILLIAMS, DA
    WITTE, ON
    JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04): : 915 - 923
  • [10] Targeting CAR T Resistance Due to CD19 Loss with CD79b-Specific CAR T Cells in B-Cells Malignancies
    Chu, Fuliang
    Weng, Jinsheng
    Kuang, Shao-Qing
    Cheng, Xiaoyun
    Cao, JingJing
    Liu, Jingwei
    Karri, Swathi
    Reddy, Adithi
    Neelapu, Sattva S.
    BLOOD, 2018, 132